The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications.
The 'healthy cell bias of estrogen action' hypothesis examines the role that regulating mitochondrial function and bioenergetics play in promoting neural health and the mechanistic crossroads that lead to divergent outcomes following estrogen exposure. Estrogen-induced signaling pathways in hippocampal and cortical neurons converge upon the mitochondria to enhance aerobic glycolysis coupled to the citric acid cycle, mitochondrial respiration and ATP generation. Convergence of estrogen-induced signaling onto mitochondria is also a point of vulnerability when activated in diseased neurons which exacerbates degeneration through increased load on dysregulated calcium homeostasis. As the continuum of neurological health progresses from healthy to unhealthy so too do the benefits of estrogen or hormone therapy. The healthy cell bias of estrogen action hypothesis provides a lens through which to assess disparities in outcomes across basic and clinical science and on which to predict outcomes of estrogen interventions for sustaining neurological health and preventing age-associated neurodegenerative diseases such as Alzheimer's.
Brinton
Roberta Diaz
RD
Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, School of Pharmacy Pharmaceutical Sciences Center, Los Angeles, CA 90033, USA. rbrinton@usc.edu
D000818:Animals; D004734:Energy Metabolism / Q000187:drug effects*; D004967:Estrogens / Q000494:pharmacology*; D006801:Humans; D008928:Mitochondria / Q000187:drug effects* / Q000502:physiology; D008954:Models, Biological; D009422:Nervous System Diseases / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control; D009474:Neurons / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure
D004967:Estrogens
Neurology. 2000 Jan 25;54(2):295-301
10668686
JAMA. 2002 Nov 6;288(17):2170-2
12413378
Annu Rev Genet. 2005;39:359-407
16285865
Age (Dordr). 2009 Sep;31(3):199-210
19277902
Ann N Y Acad Sci. 1989;568:1-4
2629579
JAMA. 1998 Mar 4;279(9):688-95
9496988
Neuroscience. 2005;132(2):299-311
15802184
J Neurosci. 2006 Oct 11;26(41):10332-48
17035515
Endocrine. 2001 Apr;14(3):407-15
11444439
Neuroimage. 2008 Apr 15;40(3):1214-21
18280754
Endocrinology. 2008 Jul;149(7):3306-12
18356271
BMC Neurosci. 2006 Nov 03;7:74
17083736
J Neurosci. 2007 Mar 21;27(12):3098-110
17376971
J Nucl Med. 2008 Mar;49(3):390-8
18287270
Brain Res. 2002 Mar 15;930(1-2):216-34
11879813
Am J Epidemiol. 2008 Mar 15;167(6):692-700
18218608
J Neurosci. 2007 Dec 19;27(51):14069-77
18094246
Ann N Y Acad Sci. 2005 Jun;1052:57-74
16024751
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19067-72
18003925
Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1463-5
16283181
Biochim Biophys Acta. 1992 Feb 3;1133(3):301-6
1531302
Ann N Y Acad Sci. 2005 Jun;1052:75-90
16024752
J Appl Physiol (1985). 2001 Oct;91(4):1860-7
11568173
Nat Med. 2002 Dec;8(12):1390-7
12415260
Brain Res Rev. 2008 Mar;57(2):421-30
17512984
JAMA. 2002 Nov 6;288(17):2123-9
12413371
J Pharmacol Exp Ther. 2008 Jun;325(3):782-90
18354059
Neurobiol Aging. 2000 Mar-Apr;21(2):373-83
10867223
Endocrinology. 2006 Nov;147(11):5303-13
16916950
J Neurosci. 2003 May 1;23(9):3807-19
12736351
JAMA. 2003 May 28;289(20):2717-9
12771119
JAMA. 2004 Jun 23;291(24):2947-58
15213206
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9893-8
8790427
Neurobiol Aging. 2006 Feb;27(2):306-17
15961189
Learn Mem. 2001 May-Jun;8(3):121-33
11390632
Neurobiol Aging. 1987 Jul-Aug;8(4):346-7
3627350
Endocrinology. 2002 Jan;143(1):205-12
11751611
JAMA. 2003 May 28;289(20):2651-62
12771112
Mol Cell Endocrinol. 2008 Aug 13;290(1-2):51-9
18571833
Neuroscience. 2006;138(3):831-5
16310320
Curr Drug Targets CNS Neurol Disord. 2004 Aug;3(4):297-313
15379606
Mol Interv. 2006 Feb;6(1):26-35
16507748
Mol Pharmacol. 2005 Oct;68(4):959-65
15994367
J Neurosci. 2008 Feb 6;28(6):1410-20
18256261
Psychoneuroendocrinology. 2007 Aug;32 Suppl 1:S57-61
17618061
Trends Neurosci. 2004 Oct;27(10):614-20
15374673
Neurobiol Aging. 2000 May-Jun;21(3):475-96
10858597
Ann N Y Acad Sci. 2000 Apr;903:204-21
10818509
J Neurochem. 1992 May;58(5):1923-9
1373180
Nature. 2006 Oct 19;443(7113):787-95
17051205
Horm Behav. 1998 Oct;34(2):171-82
9799627
Annu Rev Biochem. 2007;76:781-821
17506638
FASEB J. 2001 Apr;15(6):907-15
11292650
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2173-8
14769913
Neuroscience. 2005;135(1):59-72
16084662
Genes Dev. 2001 Jun 1;15(11):1406-18
11390360
J Neurol Sci. 2007 Jun 15;257(1-2):206-14
17316694
Nat Rev Neurosci. 2002 Nov;3(11):862-72
12415294
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2842-7
12604781
Cell Death Differ. 2008 Mar;15(3):521-9
18064042
Neurobiol Aging. 2005 Feb;26(2):229-35
15582750
Front Biosci. 2008 Jan 01;13:1083-9
17981614
Cell. 2008 Jun 27;133(7):1149-61
18585350
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):284-9
14688411
Front Biosci. 2007 Jan 01;12:1008-13
17127355
Mol Aspects Med. 2004 Feb-Apr;25(1-2):17-26
15051313
J Neurosci. 2006 Sep 13;26(37):9439-47
16971528
Mol Psychiatry. 2006 Aug;11(8):721-36
16786033
Psychoneuroendocrinology. 1986;11(3):337-45
3786638
Front Neuroendocrinol. 2008 Jan;29(1):88-113
17980408
JAMA. 2000 Feb 23;283(8):1007-15
10697060
Nature. 2004 Aug 5;430(7000):631-9
15295589
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4441-6
18332434